| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 21 May 2024 | 14 May 2024 |
| Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2024 Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2024 Outcome of Board Meeting (As Per BSE Announcement Dated on 21/05/2024) | ||
| Board Meeting | 2 Feb 2024 | 26 Jan 2024 |
| Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023. Please find attached herewith, Unaudited Financial Results (Standalone & Consolidated) For quarter and nine months ended December 31, 2023. Please find attached herewith, Outcome of Board meeting held today i.e friday, January 01, 2024 (As per BSE Announcement Dated on 02/02/2024) | ||
| Board Meeting | 4 Nov 2023 | 29 Oct 2023 |
| Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Saturday November 04 2023 to inter alia Consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and half year ended September 30 2023. Consider and approve the declaration of Interim Dividend for the Financial Year 2023-24 if any. METROPOLIS HEALTHCARE LIMITED has informed BSE about Board Meeting to be held on 04 Nov 2023 to consider financial statements for the period ended September 2023. Financial results / Dividend. This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the record date. Please find attached herewith, outcome of the Board Meeting held today i.e Saturday, 4th November, 2023 This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved and declared payment of an Interim dividend at the rate of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the Record Date. Please find attached herewith the financial results for the quarter and half year ended September 30, 2023. This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the record date. (As Per BSE Announcement Dated on 04.11.2023) This is to inform you that the Company on Sunday, November 05 has published an extract of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2023 as approved by the Board of Directors of the Company in their Meeting held on Saturday, November 04, 2023. Please find enclosed , the copy published in Free Press Journal (English) and Navshakti (Marathi). (As Per BSE Announcement Dated on 05.11.2023) | ||
| Board Meeting | 2 Aug 2023 | 26 Jul 2023 |
| Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 ,inter alia, to consider and approve We wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 02, 2023, to inter alia, Consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2023; Further, we also wish to inform you that in terms of the Companys Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company has been closed for the Designated Persons of the Company and their immediate relatives with effect from July 01, 2023 and shall re-open 48 hours after the declaration of the Financial Results of the Company for the quarter ended June 30, 2023, as intimated to the stock exchanges vide its letter MHL/Sec&Legal/2023-24/25 dated June 29, 2023. Please find attached herewith, Unaudited Financial results (standalone and consolidated) for quarter ended June 30, 2023 This is to inform you that, the Board of Directors of the Company in their meeting held today i.e August 02, 2023, have inter alia approved few agendas, details of which are enclosed herewith. (As per BSE Announcement Dated on 02/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
